Frankfurt - Delayed Quote EUR
COMPASS Pathways plc (5Y6.F)
3.3600
+0.0200
+(0.60%)
At close: April 25 at 3:29:02 PM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Kabir Kumar Nath M.A., M.B.A. | CEO & Director | 1.15M | -- | 1964 |
| Dr. Guy Goodwin | Chief Medical Officer | 498.66k | -- | 1948 |
| Ms. Teri Loxam M.B.A. | CFO, Principal Financial Officer & Principal Accounting Officer | -- | -- | 1973 |
| Dr. Greg Ryslik Ph.D. | Chief Technology Officer | -- | -- | -- |
| Mr. Stephen D. Schultz | Senior Vice President of Investor Relations | -- | -- | -- |
| Ms. Anne Benedict | Chief People Officer | -- | -- | -- |
| Mr. Lars Christian Wilde | Senior Advisor | -- | -- | 1986 |
| Dr. Susan C. Stansfield Ph.D. | Advisor | -- | -- | -- |
| Dr. Michael Gold M.D., M.Sc. | Chief Research & Development Officer | -- | -- | 1961 |
| Ms. Lori Englebert M.B.A. | Chief Commercial Officer | -- | -- | 1979 |
COMPASS Pathways plc
33 Broadwick Street
London, W1F 0DQ
United Kingdom
- Sector:
- Healthcare
- Industry: Medical Care Facilities
- Full Time Employees:
- 166
Description
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Corporate Governance
COMPASS Pathways plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 6, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
COMPASS Pathways plc Earnings Date
Recent Events
Recent Events Information Not Available